Nuclear Medicine Market Size, Share & Trends Analysis Report By Product (Diagnostics, Therapeutics), By Application, By Region (North America, APAC, Europe), And Segment Forecasts, 2018 - 2025

  • ID: 4621710
  • Report
  • Region: Asia Pacific, Europe, North America, United States
  • 137 pages
  • Grand View Research
1 of 5

FEATURED COMPANIES

  • Bracco Imaging S.P.A
  • Eckert & Ziegler Group
  • Eczacibasi - Monrol
  • GE Healthcare
  • Mallinckrodt
  • Nordion, Inc.
  • MORE
The global radiopharmaceuticals/nuclear medicine market size is expected to reach USD 15.2 billion by 2025, registering a 10.1% CAGR during the forecast period. The burden of chronic diseases such as cancer and cardiac disorders is on a rise. Nuclear medicine is widely used for diagnosis as well as treatment of such disorders.

Increasing prevalence of these disorders has a direct impact on usage of radiopharmaceuticals. As per data published by the World Health Organization (WHO), cancer is the second leading cause of death around the globe and in 2015, accounted for 8.8 million deaths. This is anticipated to drive demand for radiopharmaceuticals in the years to come.

Diagnostics, when combined with nuclear medicine, improve accuracy to a great extent. This can have a direct impact on decision-making and treatment monitoring processes. Adoption of PET as a diagnostic tool is rapidly increasing since it has shown greater precision over other diagnostic techniques.

Further key findings from the report suggest:
  • By product, the nuclear medicine market was dominated by the diagnostic segment in 2015, driven primarily by advancements in scanning technologies
  • The therapeutic segment, which comprises alpha emitters, beta emitters, and brachytherapy, is anticipated to exhibit lucrative growth over the coming years
  • On the basis of application, diagnostic formed the largest segment in 2015, including key areas such as cardiology, neurology, oncology, and thyroid
  • North America dominated the global radiopharmaceuticals market in 2015 owing to well-planned policies, favorable reimbursement structure, high healthcare spending, and increasing awareness
  • Asia Pacific is expected to witness lucrative growth in the coming years. Increasing per capita income and reform in policies is attracting market players
  • Key players in the industry include Eckert & Ziegler Group; Mallinckrodt Pharmaceuticals; GE Healthcare; Jubilant Life Sciences; Bracco Imaging S.p.A; and Nordion, Inc.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Bracco Imaging S.P.A
  • Eckert & Ziegler Group
  • Eczacibasi - Monrol
  • GE Healthcare
  • Mallinckrodt
  • Nordion, Inc.
  • MORE
Chapter 1 Methodology And Scope
1.1 Research Methodology
1.2 Research Scope And Assumptions
1.3 List Of Abbreviations

Chapter 2 Executive Summary
2.1 Market Summary

Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation

Chapter 4 Market Definitions

Chapter 5 Industry Outlook
5.1 Market Variable Analysis
5.1.1 Rising Incidence Of Cancer And Cardiovascular Disease
5.1.2 Widening Applications Of Radiopharmaceuticals
5.1.3 Growing Demand For The Accurate Diagnostic Methods
5.2 Market Restraint Analysis
5.2.1 Stringent Regulation For Production, Storage, And Usage
5.2.2 High Cost Involved With Diagnostics And Therapeutic Procedures

Chapter 6 Business Environment Aanalysis
6.1 SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
6.2 Porter’s Five Forces Analysis
6.3 Value Chain Analysis

Chapter 7 Regulatory And Political Forces
7.1 Regulatory Landscape
7.1.1 List Of Factors/ Regulations By Country
7.1.1.1 North America
7.1.1.1.1 U.S.
7.1.1.1.2 Canada
7.1.1.2 Europe
7.1.1.3 Asia Pacific
7.1.1.3.1 China
7.1.1.3.2 Japan
7.1.1.3.3 India
7.1.1.3.4 Australia/New Zealand
7.1.1.3.5 Korea
7.1.1.3.6 Singapore
7.1.1.3.7 Malaysia
7.1.1.3.8 Philippines
7.1.1.4 Middle East & Africa
7.1.1.4.1 South Africa
7.1.1.4.2 Gcc
7.1.1.5 Latin America
7.1.1.5.1 Brazil
7.1.1.5.2 Mexico
7.1.1.5.3 Argentina
7.2 Production Process And Trends
7.2.1 Production Process And Trends
7.2.1.1 Production Of Mo - 99 (SPECT Radioisotopes)
7.2.1.2 SPECT Radioisotopes Trends
7.2.1.3 PET Radioisotopes Trends
7.2.1.4 Therapeutic Radioisotopes Trends
7.2.1.5 Latest Developments

Chapter 8 Product Business Analysis
8.1 Radiopharmaceuticals Market: Product Movement Analysis
8.1.1 Diagnostic Products
8.1.1.1 Diagnostic Products Market, 2013 - 2025 (USD Million)
8.1.1.2 SPECT
8.1.1.3 SPECT Products Market, 2013 - 2025 (USD Million)
8.1.1.4 TC - 99m
8.1.1.4.1 TC - 99m Market, 2013 - 2025 (USD Million)
8.1.1.5 TL - 201
8.1.1.5.1 TL - 201 Market, 2013 - 2025 (USD Million)
8.1.1.6 GA - 67
8.1.1.6.1 GA - 67 Market, 2013 - 2025 (USD Million)
8.1.1.7 I - 123
8.1.1.7.1 I - 123 Market, 2013 - 2025 (USD Million)
8.1.1.8 Other SPECT Products
8.1.1.8.1 Other SPECT Products Market, 2013 - 2025 (USD Million)
8.1.1.9 PET
8.1.1.10 PET Products Market, 2013 - 2025 (USD Million)
8.1.1.11 F - 18
8.1.1.11.1 F - 18 Market, 2013 - 2025 (USD Million)
8.1.1.12 SR - 82/RB - 82
8.1.1.12.1 SR - 82/RB - 82 Market, 2013 - 2025 (USD Million)
8.1.1.13 Other PET Products
8.1.1.13.1 Other PET Products Market, 2013 - 2025 (USD Million)
8.1.1.2 Therapeutic Products
8.1.1.2.1 Therapeutic Products Market, 2013 - 2025 (USD Million)
8.1.1.2.2 Alpha Emitters
8.1.1.2.3 Alpha Emitters Market, 2013 - 2025 (USD Million)
8.1.1.2.4 RA - 223
8.1.1.2.4.1 RA - 223 Market, 2013 - 2025 (USD Million)
8.1.1.2.1.5 Other Alpha Emitters
8.1.1.2.5.1 Other Alpha Emitters Market, 2013 - 2025 (USD Million)
8.1.1.2.1.6 Beta Emitters
8.1.1.2.1.7 Beta Emitters Market, 2013 - 2025 (USD Million)
8.1.1.2.1.8 I - 131
8.1.1.2.8.1 I - 131 Market, 2013 - 2025 (USD Million)
8.1.1.2.1.9 Y - 90
8.1.1.2.9.1 Y - 90 Market, 2013 - 2025 (USD Million)
8.1.1.2.1.10 SM - 153
8.1.1.2.10.1 SM - 153 Market, 2013 - 2025 (USD Million)
8.1.1.2.1.11 Re - 186
8.1.1.2.11.1 Re - 186 Market, 2013 - 2025 (USD Million)
8.1.1.2.1.12 Lu - 117
8.1.1.2.12.1 Lu - 177 Market, 2013 - 2025 (USD Million)
8.1.1.2.1.13 Other Beta Emitters
8.1.1.2.13.1 Other Beta Emitters Market, 2013 - 2025 (USD Million)
8.1.1.2.1.14 Brachytherapy
8.1.1.2.1.15 Brachytherapy Market, 2013 - 2025 (USD Million)
8.1.1.2.1.16 Cesium - 131
8.1.1.2.16.1 Cesium - 131 Market, 2013 - 2025 (USD Million)
8.1.1.2.1.17 Iodine - 125
8.1.1.2.17.1 Iodine - 125 Market, 2013 - 2025 (USD Million)
8.1.1.2.1.18 Palladium - 103
8.1.1.2.18.1 Palladium - 103 Market, 2013 - 2025 (USD Million)
8.1.1.2.1.19 Iridium - 192
8.1.1.2.19.1 Iridium - 192 Market, 2013 - 2025 (USD Million)
8.1.1.2.1.20 Other Brachytherapy Products
8.1.1.2.20.1 Other Brachytherapy Products Market, 2013 - 2025 (USD Million)

Chapter 9 Application Mode Business Analysis
9.1 Radiopharmaceuticals Market: Application Movement Analysis.
9.1.1 Diagnostic Application
9.1.1.1 Diagnostic Application Market, 2013 - 2025 (USD Million)
9.1.1.2 Cardiology
9.1.1.3 Cardiology Applications Market, 2013 - 2025 (USD Million)
9.1.1.4 Neurology
9.1.1.5 Neurology Applications Market, 2013 - 2025 (USD Million)
9.1.1.6 Oncology
9.1.1.7 Oncology Applications Market, 2013 - 2025 (USD Million)
9.1.1.8 Thyroid
9.1.1.9 Thyroid Applications Market, 2013 - 2025 (USD Million)
9.1.1.10 Lymphoma
9.1.1.11 Lymphoma Applications Market, 2013 - 2025 (USD Million)
9.1.1.12 Other Diagnostic Application
9.1.1.13 Other Diagnostic Applications Market, 2013 - 2025 (USD Million)
9.1.2 Therapeutic Application
9.1.2.1 Therapeutic Application Market, 2013 - 2025 (USD Million)
9.1.2.2 Thyroid
9.1.2.3 Thyroid Applications Market, 2013 - 2025 (USD Million)
9.1.2.4 Bone Metastasis
9.1.2.5 Bone Metastasis Applications Market, 2013 - 2025 (USD Million)
9.1.2.6 Lymphoma
9.1.2.7 Lymphoma Applications Market, 2013 - 2025 (USD Million)
9.1.2.8 Endocrine Tumor
9.1.2.9 Endocrine Tumor Market, 2013 - 2025 (USD Million)
9.1.2.10 Other Therapeutic Application
9.1.2.11 Other Therapeutic Applications Market, 2013 - 2025 (USD Million)

Chapter 10 Regional Business Analysis
10.1 Radiopharmaceuticals Market: Regional Movement Analysis
10.1.1 North America
10.1.1.1 North America Market Estimates And Forecast, 2013 - 2025
10.1.1.2 U.S.
10.1.1.2.1 U.S. Market Estimates And Forecast, 2013 - 2025
10.1.1.3 Canada
10.1.1.3.1 Canada Market Estimates And Forecast, 2013 - 2025
10.1.2 Europe
10.1.2.1 Europe Market Estimates And Forecast, 2013 - 2025
10.1.2.2 Germany
10.1.2.2.1 Germany Market Estimates And Forecast, 2013 - 2025
10.1.2.3 U.K.
10.1.2.3.1 U.K. Market Estimates And Forecast, 2013 - 2025
10.1.2.4 France
10.1.2.4.1 France Market Estimates And Forecast, 2014 - 2025
10.1.2.5 Italy
10.1.2.5.1 Italy Market Estimates And Forecast, 2013 - 2025
10.1.2.6 Spain
10.1.2.6.1 Spain Market Estimates And Forecast, 2013 - 2025
10.1.2.7 Russia
10.1.2.7.1 Russia Market Estimates And Forecast, 2013 - 2025
10.1.2.8 Netherlands
10.1.2.8.1 Netherlands Market Estimates And Forecast, 2013 - 2025
10.1.3 Asia Pacific
10.1.3.1 Asia Pacific Market Estimates And Forecast, 2013 - 2025
10.1.3.2 Japan
10.1.3.2.1 Japan Market Estimates And Forecast, 2013 - 2025
10.1.3.3 China.
10.1.3.3.1 China Market Estimates And Forecast, 2013 - 2025
10.1.3.1.4 India
10.1.3.1.4.1 India Market Estimates And Forecast, 2014 - 2025
10.1.3.1.5 Australia
10.1.3.1.5.1 Australia Market Estimates And Forecast, 2013 - 2025
10.1.3.1.6 Singapore
10.1.3.1.6.1 Singapore Market Estimates And Forecast, 2014 - 2025
10.1.3.1.7 Malaysia
10.1.3.1.7.1 Malaysia Market Estimates And Forecast, 2013 - 2025
10.1.3.1.8 New Zealand
10.1.3.1.8.1 New Zealand Market Estimates And Forecast, 2013 - 2025
10.1.3.1.9 Korea
10.1.3.1.9.1 Korea Market Estimates And Forecast, 2013 - 2025
10.1.3.1.10 Philippines
10.1.3.1.10.1 Philippines Market Estimates And Forecast, 2013 - 2025
10.1.4 Latin America
10.1.4.1 Latin America Market Estimates And Forecast, 2013 - 2025
10.1.4.2 Brazil
10.1.4.2.1 Brazil Market Estimates And Forecast, 2013 - 2025
10.1.4.3 Mexico
10.1.4.3.1 Mexico Market Estimates And Forecast, 2013 - 2025
10.1.4.4 Argentina
10.1.4.4.1 Argentina Market Estimates And Forecast, 2013 - 2025
10.1.5 Middle East & Africa
10.1.5.1 Middle - East And Africa Market Estimates And Forecast, 2013 - 2025
10.1.5.2 Saudi Arabia
10.1.5.2.1 Saudi Arabia Market Estimates And Forecast, 2013 - 2025
10.1.5.3 South Africa
10.1.5.3.1 South Africa Market Estimates And Forecast, 2013 - 2025
10.1.5.4 Israel
10.1.5.4.1 Israel Market Estimates And Forecast, 2013 - 2025
10.1.5.1.5 Turkey
10.1.5.5.1 Turkey Market Estimates And Forecast, 2013 - 2025

Chapter 11 Company Profile
11.1 Eckert & Ziegler Group
11.1.1 Company Overview
11.1.2 Financial Performance
11.1.3 Product Benchmarking
11.1.4 Strategic Initiatives
11.2 Mallinckrodt
11.2.1 Company Overview
11.2.2 Financial Performance
11.2.3 Product Benchmarking
11.2.4 Strategic Initiatives
11.3 GE Healthcare
11.3.1 Company Overview
11.3.2 Financial Performance
11.3.3 Product Benchmarking
11.4 Jubilant Life Sciences Ltd.
11.4.1 Company Overview
11.4.2 Financial Performance
11.4.3 Product Benchmarking
11.4.4 Strategic Initiatives
11.5 Bracco Imaging S.P.A
11.5.1 Company Overview
11.5.2 Financial Performance
11.5.3 Product Benchmarking
11.5.4 Strategic Initiatives
11.6 Nordion, Inc.
11.6.1 Company Overview
11.6.2 Financial Performance
11.6.3 Product Benchmarking
11.6.4 Strategic Initiatives
11.7 The Institute For Radioelements (IRE)
11.7.1 Company Overview
11.7.2 Financial Performance
11.7.3 Product Benchmarking
11.7.4 Strategic Initiatives
11.8 Australian Nuclear Science & Technology Organization (ANSTO)
11.8.1 Company Overview
11.8.2 Financial Performance
11.8.3 Product Benchmarking
11.9 NTP Radioisotopes SOC Ltd.
11.9.1 Company Overview
11.9.2 Financial Performance
11.9.3 Product Benchmarking
11.9.4 Strategic Initiatives
11.10 Eczacibasi - Monrol
11.10.1 Company Overview
11.10.2 Financial Performance
11.10.3 Product Benchmarking

Chapter 12 KOL Commentary
12.1 Key Insights
12.2 KOL Views

Chapter 13 Recommendations
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Eckert & Ziegler Group
  • Mallinckrodt
  • GE Healthcare
  • Jubilant Life Sciences Ltd.
  • Bracco Imaging S.P.A
  • Nordion, Inc.
  • The Institute For Radioelements (IRE)
  • Australian Nuclear Science & Technology Organization (ANSTO)
  • NTP Radioisotopes SOC Ltd.
  • Eczacibasi - Monrol
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4621710
Adroll
adroll